REFERENCES
- Lown KS, Bailey DG, Fontana RJ, Janardan SK, Adair CH, Fortlage LA, Brown MB, Guo W, Watkins PB. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. J Clin Invest 1997;99:2545–2553.
- Schmiedlin-Ren P, Edwards DJ, Fitzsimmons ME, He K, Lown KS, Woster PM, Rahman A, Thummel KE, Fisher JM, Hollenberg PF, Watkins PB. Mechanism of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins. Drug Metab Dipos 1997;25:1228–1233.
- Tassaneeyakul W, Guo LQ, Fukuda K, Ohta T, Yamazoe Y. Inhibition selectivity of grapefruit juice component on human cytochromes P450. Arch Biochem Biophys 2000;378:356–363.
- Muller FO. Estimation of the bioavailability of nisoldipine in man. Abstracts of the Nisoldipine Workshop, October 1986, Luxembourg, Belgium.
- Edgar B, Regardh CG, Johnson G, Johansson L, Lundborg P, Löfberg I, Rönn O. Felodipine kinetics in healthy men. Clin Pharmacol Ther 1985;38:205–211.
- Bailey DG, Spence JD, Munoz C, Arnold JM. Interaction of citrus juices with felodipine and nifedipine. Lancet 1991;337(8736):268–269.
- Azuma J, Yamamoto I, Watase T, Orii Y, Tanigawa T, Terashima S, Yoshikawa K, Tanaka T, Kawano K. Effects of grapefruit juice on the pharmacokinetics of calcium channel blockers nifedipine and nisoldipine. Curr Ther Res 1998;59:619–633.
- Oohashi N. A case of increased blood amlodipine level after continuous grapefruit consumption. Meeting of Internal Medicine in Tokai Region, 2001, Vol. 183, p. 73 ( in Japanese).
- Josefsson M, Zackrisson AL, Ahlner J. Effect of grapefruit juice on the pharmacokinetics of amlodipine in healthy volunteers. Eur J Clin Pharmacol 1996;51:189–193.
- Vincent J, Foulds G, Dogolo LC, Willavize SA, Friedman HL. Grapefruit juice does not alter the pharmacokinetics of amlodipine in man. Clin Pharmacol Ther 1997;61:233.
- Rashid J, McKinstry C, Renwick AG, Dirnhuber M, Waller DG, Georage CF. Quercetin, an in vitro inhibitor of CYP3A, does not contribute to the interaction between nifedipine and grapefruit juice. Br J Clin Pharmacol. 1993;36:460–463.
- Sigusch H, Hippius M, Henschel L, Kaufmann K, Hoffmann A. Influence of grapefruit juice on the pharmacokinetics of a slow release nifedipine formation. Pharmazie. 1994;49:522–524.
- Rashid TJ, Martin U, Clarke H, Waller DG, Renwick AG, George CF. Factors affecting the absolute bioavailability of nifedipine. Br J Clin Pharmacol. 1995;40:51–58.
- Tanaka T, Okumura K, Orii Y, Hasizume N, Tsuboi T, Tanikawa M, Kouno K, Katoh M, Hashimoto K, Sekino H, Kamata S, Nomura M, Matsuoka O, Tateishi T. Effect of grapefruit juice on the pharmacokinetics of Adalat CR. In Proceedings of the 20th Annual Meeting of the Japanese Society of Clinical Pharmacology and Therapeutics, 1999, p. 58.
- Ohtani M, Kawabata S, Kariya S, Uchino K, Itou K, Kotaki H, Kasuyama K, Morioka A, Seo I, Nishida N. Effect of grapefruit pulp on the pharmacokinetics of the dihydropyridine calcium antagonists Nifedipine and Nisoldipine. Yakugaku Zassi. 2002;122:323–329.
- Takanaga H, Ohnishi A, Murakami H, Murakami H, Matsuo H, Higashi S, Urae A, Irie S, Furuie H, Matsukuma K, Kimura M, Kawano K, Orii Y, Tanaka T, Sawada Y. Relationship between time after intake of grapefruit juice and the effect on pharmacokinetics and pharmacodynamics of nisoldipine in healthy subjects. Clin Pharmacol Ther 2000;67:201–214.
- Niwa T, Shiraga T, Ishii I, Kagayama A, Takagi A. Contribution of human hepatic cytochrome P450 isoforms to the metabolism of psychotropic drugs. Biol Pharm Bull 2005;28:1711–1716.